80 related articles for article (PubMed ID: 2553587)
1. Autocrine regulation of 1,25-dihydroxycholecalciferol metabolism in myelomonocytic cells.
Hewison M; Barker S; Brennan A; Nathan J; Katz DR; O'Riordan JL
Immunology; 1989 Oct; 68(2):247-52. PubMed ID: 2553587
[TBL] [Abstract][Full Text] [Related]
2. The comparative role of 1,25-dihydroxycholecalciferol and phorbol esters in the differentiation of the U937 cell line.
Hewison M; Brennan A; Singh-Ranger R; Walters JC; Katz DR; O'Riordan JL
Immunology; 1992 Oct; 77(2):304-11. PubMed ID: 1330898
[TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxycholecalciferol-induced differentiation of myelomonocytic leukemic cells unresponsive to colony stimulating factors and phorbol esters.
Bettens F; Schlick E; Farrar W; Ruscetti F
J Cell Physiol; 1986 Dec; 129(3):295-302. PubMed ID: 3491083
[TBL] [Abstract][Full Text] [Related]
4. Impaired nuclear localization of vitamin D receptor in leukemia cells resistant to calcitriol-induced differentiation.
Humeniuk-Polaczek R; Marcinkowska E
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):361-6. PubMed ID: 15145445
[TBL] [Abstract][Full Text] [Related]
5. Transfection of vitamin D receptor cDNA into the monoblastoid cell line U937. The role of vitamin D3 in homotypic macrophage adhesion.
Hewison M; Dabrowski M; Faulkner L; Hughson E; Vadher S; Rut A; Brickell PM; O'Riordan JL; Katz DR
J Immunol; 1994 Dec; 153(12):5709-19. PubMed ID: 7989768
[TBL] [Abstract][Full Text] [Related]
6. Signaling of monocytic differentiation by a non-hypercalcemic analog of vitamin D3, 1,25(OH)2-5,6 trans-16-ene-vitamin D3, involves nuclear vitamin D receptor (nVDR) and non-nVDR-mediated pathways.
Ji Y; Wang X; Donnelly RJ; Uskokovic MR; Studzinski GP
J Cell Physiol; 2002 May; 191(2):198-207. PubMed ID: 12064463
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
[TBL] [Abstract][Full Text] [Related]
8. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
[TBL] [Abstract][Full Text] [Related]
9. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
Seifert M; Rech M; Meineke V; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):375-9. PubMed ID: 15225804
[TBL] [Abstract][Full Text] [Related]
10. Antisense inhibition of vitamin D receptor expression induces apoptosis in monoblastoid U937 cells.
Hewison M; Dabrowski M; Vadher S; Faulkner L; Cockerill FJ; Brickell PM; O'Riordan JL; Katz DR
J Immunol; 1996 Jun; 156(11):4391-400. PubMed ID: 8666812
[TBL] [Abstract][Full Text] [Related]
11. Regulation of c-fgr messenger RNA levels in U937 cells treated with different modulating agents.
Faulkner L; Patel M; Brickell PM; Katz DR
Immunology; 1992 May; 76(1):65-71. PubMed ID: 1628903
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of neoplastic cells toward normal induced by vitamin D3 derivatives.
Srivastava MD; DeLuca HF; Ambrus JL
Res Commun Chem Pathol Pharmacol; 1994 Feb; 83(2):115-23. PubMed ID: 8202625
[TBL] [Abstract][Full Text] [Related]
13. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG
J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365
[TBL] [Abstract][Full Text] [Related]
14. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
Gyetko MR; Webb AC; Sitrin RG
J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
[TBL] [Abstract][Full Text] [Related]
16. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
[TBL] [Abstract][Full Text] [Related]
17. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
18. Functional antagonism between vitamin D3 and retinoic acid in the regulation of CD14 and CD23 expression during monocytic differentiation of U-937 cells.
Oberg F; Botling J; Nilsson K
J Immunol; 1993 Apr; 150(8 Pt 1):3487-95. PubMed ID: 7682243
[TBL] [Abstract][Full Text] [Related]
19. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.
Barreto AM; Schwartz GG; Woodruff R; Cramer SD
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):265-70. PubMed ID: 10750664
[TBL] [Abstract][Full Text] [Related]
20. Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3.
Nunn JD; Katz DR; Barker S; Fraher LJ; Hewison M; Hendy GN; O'Riordan JL
Immunology; 1986 Dec; 59(4):479-84. PubMed ID: 3026959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
